Related Experiment Video

Updated: Sep 22, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.8K

Talazoparib in BRCA-mutated advanced breast cancer: is earlier better?

Mariana Boulos1, Elissar Moujaes1, Ghazi Nsouli2

  • 1Hematology-Oncology Department, Saint Joseph University of Beirut, Lebanon.

Pharmacogenomics
|May 24, 2022
PubMed

Insights

Talazoparib improves survival and quality of life for patients with BRCA mutations in breast cancer. Optimal treatment sequencing for BRCA-mutated breast cancer requires personalized, case-by-case evaluation.

Area of Science:

  • Oncology
  • Pharmacology
  • Genetics

Background:

  • Talazoparib is an approved oral PARP inhibitor for advanced/metastatic breast cancer.
  • Its optimal use in BRCA-mutated breast cancer, first-line versus later lines, lacks consensus.
  • Other effective treatments, including immune checkpoint inhibitors, are emerging.

Purpose of the Study:

  • To evaluate the efficacy and safety of talazoparib in BRCA-mutated breast cancer.
  • To discuss the optimal treatment sequencing for talazoparib in this patient population.

Main Methods:

  • Comparative analysis of talazoparib versus chemotherapy.
  • Review of survival and quality of life data.
  • Assessment of toxicity profiles.

Main Results:

  • Talazoparib demonstrated superiority over chemotherapy in survival and quality of life for BRCA-mutated breast cancer patients.
  • An acceptable toxicity profile was observed with talazoparib.
  • Cost and availability of newer agents may influence treatment line decisions.

Conclusions:

  • Talazoparib is effective in BRCA-mutated breast cancer, improving survival and quality of life.
  • Treatment sequencing requires personalization due to evolving therapeutic options and cost considerations.
  • Further data are needed to establish definitive treatment guidelines.
Keywords:
BRCA mutationPARP inhibitorsbreast cancertalazoparib

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.2K
Evaluating In Vitro DNA Damage Using Comet Assay10:43

Evaluating In Vitro DNA Damage Using Comet Assay

Published on: October 11, 2017

38.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
467